{
    "case_number": "CAC-UDRP-101401",
    "time_of_filling": "2017-01-03 14:36:57",
    "domain_names": [
        "novonordisk.net"
    ],
    "case_administrator": "Aneta Jelenová (Case admin)",
    "complainant": [
        "Novo Nordisk A\/S"
    ],
    "complainant_representative": "Wallberg IP Advice",
    "respondent": [
        "shilirong shilirong"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nThe Complainant is a global healthcare company almost 90 years old. Headquartered in Denmark, Complainant employs approximately 41.600 employees in 75 countries, and markets its products in more than 180 countries. The Annual turnover was 14.3 billion Euro in 2015. \r\n\r\nThe Complainant holds trademark registrations worldwide of the trademark Novo Nordisk. \r\n\r\nThe Complainant has a strong Internet presence with its main website being www.novonordisk.com. The Complainant does own numerous other domain names including domain names containing the Novo Nordisk trademark as second level domains. \r\n\r\nThe Complainant has recently become aware of the registration of the Disputed domain name <novonordisk.net>. The Registrant registered the Disputed domain name on March 23, 2016. The Disputed domain name resolves to an active website for online gambling. ",
    "other_legal_proceedings": "The panel is not aware of any other pending proceedings. The panel is, however, aware of the ADR proceedings CAC 101316 being decided with regard to the same domain name which is referred to below in the section \"Procedural factors\". ",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the Disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i)of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Disputed domain name (within the meaning of paragraph 4(a)(ii)of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the Disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii)of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.\r\n\r\nThe Disputed domain name was the subject of a previous complaint with the CAC, i.e. in case 101316. This complaint was rejected due to the fact that the forwarded renewal certificates concerning the Complainant’s trademark registrations of NOVO NORDISK in China did not show that the marks were still in force in China at the time of filing of the complaint. The panel in that case could have invited the Complainant to rectify that omission under Rule 12, but, in its best discretion, did not do so and decided the case on the given basis. \r\n\r\nThe panel of this case allows, aware of the limited circumstances where re-filings were accepted, and not at last in view of WIPO case D2001-1041, a re-filing of the Complaint in the present case, including sufficient evidence of the validity of the claimed trademark right. ",
    "decision": "Accepted",
    "panelists": [
        "Dietrich Beier"
    ],
    "date_of_panel_decision": "2017-03-01 00:00:00",
    "informal_english_translation": "The Complainant is, inter alia, the proprietor of the trademark 786062 Novo Nordisk in China registered on October 28, 1995, inter alia for pharmaceuticals, which was in accordance with the provided renewal certificate renewed until October 27, 2025.",
    "decision_domains": {
        "NOVONORDISK.NET": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}